Physician profile
Howard C Wang
NPI 1255469433
$9,496.95
in general payments reported to CMS, 2019-2025
22 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $344 · 2021: $720 · 2022: $1,112 · 2023: $2,796 · 2024: $1,868 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,816 · Travel and Lodging: $1,134 · Entertainment: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,816.20 |
| Travel and Lodging | $1,134.22 |
| Entertainment | $358.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,725.24 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $2,105.35 | 2022-2025 | Infuse, Infuse Svs |
| Coopervision INC. | $1,240.64 | 2020-2025 | Myday Contact Lens, Ortho-K Contact Lens, Misight Contact Lens |
| Optos, INC. | $517.02 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $476.97 | 2019-2021 | |
| Sight Sciences, INC. | $373.07 | 2019-2023 | Tearcare System |
| Maculogix, INC. | $359.51 | 2019-2020 | |
| Glaukos Corporation | $272.74 | 2024-2025 | Kxl System (Not Refurbished), Photrexa |
| Visioneering Technologies, INC. | $195.70 | 2019 | |
| Lumenis Be INC | $141.51 | 2024 | Optilight |
| Lkc Technologies, INC. | $126.13 | 2024 | |
| Biotissue Holdings INC. | $122.01 | 2022 | |
| Horizon Therapeutics Plc | $116.88 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $113.38 | 2019 | |
| Apellis Pharmaceuticals, INC. | $113.30 | 2023 | Syfovre |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heru, INC. | $112.01 | 2022 | |
| Dompe US, INC. | $108.00 | 2025 | Oxervate |
| Lombart Brothers, INC. | $103.78 | 2025 | Opd-III |
| Abbvie INC. | $86.69 | 2023 | |
| Allergan, INC. | $47.71 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $20.25 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $19.06 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.